Medical Treatment & Prevention

Description

No matching items found.

People

  

  

  

1 of 8

  

  

  

• ALUCK THIPAYARAT
• BOONSERM KAEWKAMNERDPONG
• CHANYAPORN BSTIELER
• DUANGHATHAI WIWATRATANA
• DUJDUAN WARAHO

Publications

  

  

  

5 of 17

  

  

  

• ● Biophysical Interpretation of Evolutionary Consequences on the SARS-CoV2 Main Protease through Molecular Dynamics Simulations and Network Topology Analysis; Sawang, Nuttawat; Phongphanphanee, Saree; Wong-Ekkabut, et al.; 2022; Journal article
• ● Boolean modeling of breast cancer signaling pathways uncovers mechanisms of drug synergy; Kittisak Taoma,Marasri Ruengjitchatchawalya,Monrudee Liangruksa , et al.; 2024; Journal article
• ● Cerium-Zinc-Strontium-Doped Mesoporous Bioactive Glass Nanoparticles for Bone Regeneration Applications; Nattakan Sae-sue, Parichart Naruphontjirakul, Nujarin Jongruja; 2025; Conference proceedings article
• ● Chapter 6 - Adult stem cells in regenerative medicine of digestive system; Zahra Mahmoudi, Hamza Mahmood, Shadi Ghalami, et al.; 2025; Chapter in book
• ● Combining Deep Learning and Structural Modeling to Identify Potential Acetylcholinesterase Inhibitors from Hericium erinaceus; Sutthibutpong, Thana; Posansee, Kewalin; Liangruksa, et al.; 2024; Journal article

Projects

  

  

  

1 of 3

  

  

  

• ● Characterizing tissue biomechanical properties for development of artificial tissue; TEERANOOT CHANTHASOPEEPHAN - Department of Mechanical Engineering
• ● Cosmeceutical mask sheet for skin care whitening and antiaging agent using innovative cellulose acetate electrospun fibers doped with a natural oxyresveratal ; NAKORN NIAMNONT - Department of Chemistry
• ● Development of a phototriggerable liposomal delivery system for emblica fruit extract for the treatment of psoriasis; KWANCHANOK PASUWAT - Department of Chemical Engineering
• ● Development of nanobodies specific to the CHRD domain of proprotein convertase subtilisin/kexin type 9 (PCSK9) as biologics for treatment of high blood LDL-cholesterol level; DUJDUAN WARAHO - Faculty of Engineering
• ● Development of nanobody specific to receptor binding domain of SARS-CoV-2 for applying as antibody drug for COVID-19 treatment; DUJDUAN WARAHO - Faculty of Engineering